Prenatal dexamethasone 'programmes' hypotension, but stress-induced hypertension in adult offspring by O'Regan, David et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Prenatal dexamethasone 'programmes' hypotension, but stress-
induced hypertension in adult offspring
Citation for published version:
O'Regan, D, Kenyon, CI, Seckl, JR & Holmes, MC 2008, 'Prenatal dexamethasone 'programmes'
hypotension, but stress-induced hypertension in adult offspring' Journal of Endocrinology, vol. 196, no. 2,
pp. 343-352. DOI: 10.1677/JOE-07-0327
Digital Object Identifier (DOI):
10.1677/JOE-07-0327
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Journal of Endocrinology
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
343Prenatal dexamethasone ‘programmes’ hypotension, but stress-induced
hypertension in adult offspringDavid O’Regan, Christopher J Kenyon, Jonathan R Seckl and Megan C Holmes
Endocrinology Unit, Queen’s Medical Research Institute, Centre for Cardiovascular Science, 47 Little France Crescent, Edinburgh EH16 4TJ, UK
(Correspondence should be addressed to M C Holmes; Email: megan.holmes@ed.ac.uk)AbstractLow birth weight in humans is predictive of hypertension in
adult life. Although the mechanisms underlying this link remain
unknown, fetal overexposure to glucocorticoids has been
implicated. We previously showed that prenatal dexamethasone
(DEX) exposure in the rat lowers birth weight and programmes
adult hypertension. The current study aimed to further
investigate the nature of this hypertension and to elucidate its
origins. Unlike previous studies, we assessed offspring blood
pressure (BP) with radiotelemetry, which is unaffected by
stress artefacts of measurement. We show that prenatal DEX
during the lastweekofpregnancy results inoffspring of low birth
weight (14% reduction) that have lower basal BP in adulthood
(w4–8 mmHg lower); with the commonly expected hyper-
tensive phenotype only being noted when these offspring areThis is an Open Access article distributed under the terms of the Society for Endo
distribution, and reproduction in any medium, provided the original work is prop
Journal of Endocrinology (2008) 196, 343–352
0022–0795/08/0196–343 q 2008 Society for Endocrinology Printed in Greatsubjected to even mild disturbance or a more severe stressor (up
to 30 mmHg higher than controls). Moreover, DEX-treated
offspring sustain their stress-induced hypertension for longer.
Promotion of systemic catecholamine release (amphetamine)
induced a significantly greater rise of BP in the DEX animals
(77% increase) over that observed in the vehicle controls.
Additionally, we demonstrate that the isolated mesenteric
vasculature of DEX-treated offspring display greater sensitivity
to noradrenaline and other vasoconstrictors. We therefore
conclude that altered sympathetic responses mediate the stress-
induced hypertension associated with prenatal DEX
programming.
Journal of Endocrinology (2008) 196, 343–352Introduction
Much evidence suggests that transient adversity in the prenatal
environment exerts permanent effects on subsequent physiology
and increases disease risk in adult life (Curhan et al. 1996b, Fall
et al. 1998, Law et al. 2001, Seckl 2004). A plethora of
epidemiological studies have shown that low birth weight, a
proposed surrogate for intrauterine adversity, is associated with
hypertension (Barker 1990), type 2 diabetes (McCance et al.
1994), the metabolic syndrome and deaths from ischemic heart
disease in later life (Curhan et al. 1996a, Barker 1999). To explain
these links, the concept of developmental ‘programming’ has
been advanced, whereby a factor acting during a critical
developmental window affects the ontogeny of specifically
vulnerable cell targets, permanently altering tissue structure
and/or function and hence the eventual risk of disease
(Benediktsson et al. 1993, Barker 2003, Seckl 2004). However,
such environmentally determined developmental effects are
widespread in the animal kingdom and often associate with
phenotypeswhich appear to represent a finely balanced transient
advantage in a particular environment. Such developmental
‘trade-offs’ can become disadvantageous late in the lifespan.
Fetal ‘programming’ may be investigated in a controlled
manner using laboratory animals that age relatively rapidly and
have similar or identical genetic backgrounds. In rats and manyother mammalian species, fetal exposure to excess glucocorti-
coids via maternal stress, inhibition of placental 11b-hydroxy-
steroid dehydrogenase type 2, the normal ‘barrier’ to maternal
glucocorticoids, or its bypass with non-substrate synthetic
glucocorticoids, such as dexamethasone (DEX), commonly
used in obstetric practice, all lower birth weight. The adult
offspring show permanently elevated glucose and insulin levels
and hypertension (Levitt et al. 1996, Nyirenda et al. 1998, 2001,
Langdown et al. 2001, Sugden et al. 2001). Although
programmed increases in the expression of key hepatic
gluconeogenic enzymes may later underpin hyperglycaemia
(Nyirenda et al. 1998, 2001), little is known of the mechanisms
by which glucocorticoids ‘programme’ higher blood pressure
(BP) or whether this phenotype carries any advantage.
Prenatal DEX, specifically in the last trimester, affects the
development and maturation of specific organs related to BP
control and maintenance; notably the developing heart,
kidney, vasculature and brain (Torres et al. 1997, Ortiz et al.
2003, Kreider et al. 2005, Roghair et al. 2005). Alterations in
the activity or responsivity of the sympathetic nervous system
(SNS), either systemically or in one of these specific regions,
could provide a potential explanation for the manner in
which prenatal glucocorticoids promote adulthood hyper-
tension. Indeed, in humans, increased SNS activity has long
been proposed as a mechanism to explain the pathogenesis ofcrinology’s Re-use Licence which permits unrestricted non-commercial use,
erly cited.
DOI: 10.1677/JOE-07-0327
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D O’REGAN and others . Prenatal programming of hypertension344glucocorticoid-induced hypertension (Whitworth et al. 1995,
Saruta 1996). Consistent with this hypothesis, elevated SNS
activity, established in utero, links small size at birth with raised
BP in adult life (Phillips & Barker 1997). In rats, prenatal
DEX alters the development of cardiac and central
sympathetic innervation and activity (Slotkin et al. 1992,
Bian et al. 1993). Permanent changes in the pattern and
expression of adrenergic receptors (Huff et al. 1991, Bian et al.
1992) have the potential to alter vascular responsivity to
vasoconstrictors. Similar findings have been reported with
DEX administration during pregnancy in sheep (Stein et al.
1994, Padbury et al. 1995, Tseng et al. 1995).
To study more closely diurnal variation and the role of the
SNS in adult BP in animals prenatally treated with excess
glucocorticoids, we used the DEX-exposed rat model. Radio-
telemetry (Anderson et al. 1999) enabled the remote recording
of BP in conscious, unrestrained rats with minimal stress effects.Materials and Methods
Animals
Adult Wistar rats (200–250 g; Harlan UK Ltd, Bichester, UK)
were maintained under conditions of controlled lighting
(lights on 0700–1900 h) and temperature (22 8C) with ad
libitum access to food (standard rat chow) and water. All
experiments were performed according to the UK Animals
(Scientific Procedures) Act, 1986.
Prenatal treatments
Virgin female rats were housed with male rats. Pregnancy was
confirmed by the presence of a vaginal plug, checked every
morning. Pregnant females were housed singly, and randomly
assigned to one of two treatment groups (nZ9–10 per group).
DEX (100 mg/kg per day, dissolved in 4% ethanol in 0.9% saline,
200 mg/ml; Sigma–Aldrich) was injected (subcutaneously) daily
(0900 h) on embryonic days 15–21 inclusive (Nyirenda et al.
1998); control animals received vehicle (VEH) injections.
Litters
On the dayof birth (postnatal day 1), litters were weighed, sexed
and culled to eight pups per litter, retaining equal numbers of
male and female pups where possible. Litters were then left
undisturbed till weaning (postnatal day 21), apart from routine
weekly maintenance. After weaning, male and female pups from
each litter were housed in single sex groups of two to four. All
rats underwent a minimum of 2 weeks of daily handling prior to
being utilised in experiments. Females were tested during
oestrus, confirmed by vaginal cytology. Epithelial cells were
aspirated from the vagina with 1 ml saline and placed on a glass
slide for microscopic inspection. The oestrous cycle was then
staged according to the Journal of Animal Technicians Association,
12, No. 1. Staging was independently verified by at least one
other researcher/animal technician.Journal of Endocrinology (2008) 196, 343–352Radiotelemetry monitoring of offspring BP, heart rate and activity
BP (systolic BP, SBP; diastolic BP, DBP; mean arterial pressure,
MAP and pulse pressure, PP), heart rate (HR), and activity
were assessed by radiotelemetry (Dataquest IV, Data Sciences
International, St Paul, MN, USA; Anderson et al. 1999).
Randomly selected littermates (five males and five females,
from eight vehicle and eight DEX litters) at 7–8 months were
anaesthetised with halothane. A flexible catheter was secured
in the abdominal aorta, and the telemetry transmitter was
sutured to the abdominal wall. On recovery, rats were housed
in individual cages, and each cage was placed over a receiver
panel with output to a PC. Each cage and its receiver panel
were housed in a specially designed steel cage rack, to prevent
radio signal disturbance from neighbouring animals, and the
rack was stored in a quiet room. After a 10-day recovery
period, haemodynamic measurements were recorded for 10 s
every 30 min (Khan et al. 2003).Induction of stress by disturbance, weighing and restraint procedure
Offspring were subjected to a series of graded stressors: i) simple
disturbance (a researcher entering their room); ii) being weighed
and iii) restraint in a Perspex cylinder for 15 min. To evaluate the
stress response toweighing, haemodynamic measurements were
recorded prior to and immediately after removal of the rat from
its cage and again at 5-min post-weighing, when the animal was
replaced. For the restraint procedure, measurements were
collected prior to the rat being placed in the cylinder,
throughout the 15-min restraint period, and at 15-min post-
restraint, on being returned to its cage. A rest period of 2 days
was allowed between experiments.Haemodynamic responses to alterations in catecholaminergic
mechanisms
Haemodynamic responses were collected for 15 min
following a low dose of i.p. D-amphetamine (0.5 mg/kg), to
cause systemic catecholamine release.Vascular responses to noradrenaline, vasopressin and potassium
chloride
Pairs of rats (one VEH and one DEX) were anaesthetised with
sodium pentobarbitone, and the mesenteric vasculature was
catheterised and perfused with Krebs bicarbonate Ringer’s
solution, and isolated as previously described (McGregor
1965). Perfusion pressure with constant flow rate was
measured continuously via an Elcomatic EM 720 transducer,
and recorded on a MacLab Chart V3.3.5 program (ADI,
Oxford, UK). On alternate days, mesenteric preparations
from each treatment group were attached to alternate
transducers, to exclude the possibility of any positional
artefact. Following a 15-min equilibration period, a brief
‘wake-up’ bolus of 20 mM noradrenaline (NA; Sigma–
Aldrich) was administered (Hadoke et al. 2006).www.endocrinology-journals.org
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Prenatal programming of hypertension . D O’REGAN and others 345Twelve pairs of mesenteric vasculature preparations from
both male and female offspring were tested simultaneously for
periods of 3 min with increasing concentrations of agonists in
the following order: NA (0.1–20 mM), vasopressin (AVP;
0.5–20 nM; Sigma–Aldrich) and potassium chloride (KCl;
25–125 mM), all agonists were prepared in Ringer’s solution.
Between tests, the vasculatures were infused with Ringer’s
solution alone, during which time the perfusion pressure
returned to basal values. A recovery period of at least 30 min
was allowed between each agonist.l
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BP, HR and activity Basal BP parameters (SBP, DBP,
MAP, PP and HR) and activities for each prenatal treatment
(VEH or DEX) and gender, are shown in Table 2A (meansG
S.D). Data are calculated for each rat as an average over 3 days
of telemetry recording. Statistical analysis of the data was by
multivariate repeated measures MANOVA (with prenatal
treatment, gender and light/dark period as dependent
variables, and rat identification number/representative of
each litter and time of day as random variables) which was
carried out on the raw BP data for each rat and significance
values for each dependent variable, together with interactions
between variables are shown in Table 2.
Values following drug treatment (amphetamine) were
analysed by three-way ANOVA with prenatal treatment,
amphetamine treatment and gender as variables, followed by
Dunnett’s post hoc test. Statistical significance was assumed at a
value of P!0.05.
Vascular studies All data are meanGS.E.M. For each
mesenteric preparation, the maximal response and the
concentration of agonist required for a 50% response (EC50)
were determined. Differences in the mean log EC50 and
maximal response values between VEH- and DEX-treated
offspring mesenteric vasculatures were compared using
Student’s unpaired t-test. Data were further analysed by
two-way ANOVA (prenatal treatment!dose of agonist);
results were considered significant when P!0.05.Ta
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.Results
Gestational weight gain, birth phenotype and catch-up growth
DEX administration throughout the final week of gestation
resulted in a significant reduction in maternal weight gain,
with no differences noted in the length of gestation, litter size,
ratio of male to female pups born or pup viability (Table 1).
Consistent with previous studies, DEX caused a significant
reduction in the birth weight of offspring, which was
observed to the same degree in both male and female pups
(O’Regan et al. 2004). By weaning (postnatal day 21) and
throughout adult life, the body weights of male and female
offspring, treated with VEH or DEX were similar, that is, fullwww.endocrinology-journals.org Journal of Endocrinology (2008) 196, 343–352
D O’REGAN and others . Prenatal programming of hypertension346catch-up growth had occurred (Table 1). Kidney size was not
apparently altered by prenatal glucocorticoid treatment in
either males (VEH: 0.005G0.0002 g/g bwt, nZ7 and DEX:
0.0051G0.00014 g/g bwt, nZ5) or females (VEH:
0.00535G0.00011 g/g bwt, nZ5 and DEX: 0.00495G
0.000177 g/g !0.001 bwt, nZ6).Radiotelemetric monitoring of offspring BP, HR and activity
under basal conditions
BP, HR and activity showed the expected sex variations and
circadian variation in male and female offspring of both the
prenatal treatment groups with the highest BP (MAP, SBP
and DBP), HR and activity levels in the dark phase and lowest
values during the light phase (Table 2 and Figs 1 and 2).
Contrary to previous reports using indirect (tail cuff) andTable 2 (A) Blood pressure parameters measured under basal conditions
(B) Table of P values resulting from MANOVA of telemetry data in A. De
day or night measurements. Results are meanGS.D. (number of observa
(A) Telemetry data
VEH _ DEX
Systolic (mmHg)
Av daily BP 144.5G10.6 (750) 140.2G15.2 (7
Av BP in light phase 141.7G9.5 (390) 138.3G16.2 (3
Av BP in dark phase 147.6G11.0 (360) 142.5G13.7 (3
Diastolic (mmHg)
Av daily BP 106.1G9.8 (750) 103.3G12.8 (7
Av BP in light phase 103.4G8.6 (390) 101.6G13.4 (3
Av BP in dark phase 109.0G10.2 (360) 105.3G11.4 (3
MAP (mmHg)
Av daily BP 118.9G10.6 (750) 115.6G15.5 (7
Av BP in light phase 116.1G8.7 (390) 113.9G14.4 (3
Av BP in dark phase 121.9G10.3 (360) 117.7G12.1 (3
Pulse pressure (mmHg)
Av daily PP 38.5G3.9 (750) 36.9G3.7 (71
Av PP in light phase 38.3G3.7 (390) 36.7G3.8 (38
Av PP in dark phase 38.7G4.2 (360) 37.2G3.6 (33
Heart Rate (beats/min)
Av daily HR 339.3G60.4 (750) 349.2G62.3 (7
Av HR in light phase 306.7G44.1 (390) 323.1G53.3 (3
Av HR in dark phase 374.6G55.7 (360) 379.6G58.4 (3
Activity (arbitrary units)
Av daily activity 2.88G2.81 (745) 2.51G2.50
Av activity in light phase 1.41G1.73 (385) 1.29G1.58
Av activity in dark phase 4.46G2.88 (360) 3.82G2.64
(B) P values resulting from MANOVA of telemetry data
PNT Day/night Gender I
Parameter
SBP 0.001 0.001 0.001
DBP 0.001 0.001 0.001
MAP 0.001 0.001 0.001
PP 0.001 0.001 0.001
HR 0.038 0.001 0.001
Activity 0.001 0.001 0.001
Bold numbers indicate significance (P!0.05) of dependent variables and intera
pressure; MAP, mean arterial pressure; PP, pulse pressure; HR, heart rate.
Journal of Endocrinology (2008) 196, 343–352direct but stressful (carotid cannulation) methods to assess BP,
both male and female DEX offspring showed basal
hypotension with lower SBP, DBP, PP and HR compared
with VEH rats (Figs 1 and 2 and Table 2), which was not
dependent on whether the measurements were taken in the
active, dark phase or the quiescent, light phase. However,
there was a significant interaction between BP parameters and
gender (Table 2), greater effects of prenatal treatment (PNT)
being apparent in the males.
It was also observed that the DEX rats were less active than
the VEH controls (Table 2), this effect was greater in the
females compared with the males (interaction of PNT and
gender, P!0.001) and was observed mostly in the active,
dark phase of the 24 h (interaction of PNT and day/night
phase, P!0.001). The reduced activity of the DEX rats may
contribute to the observed hypotension.in adult offspring of VEH- and dexamethasone (DEX)-treated dams.
pendent variables are prenatal treatment (VEH or DEX), gender and
tions), from all data collected over 72-h period for each rat
_ VEH \ DEX \
17) 138.3G10.4 (450) 129.7G12.7 (749)
86) 135.2G10.2 (234) 126.6G11.8 (390)
31) 141.6G9.5 (216) 133.1G12.8 (359)
17) 101.5G8.9 (450) 99.4G13.0 (749)
86) 99.4G8.4 (234) 96.3G12.0 (390)
31) 103.8G8.9 (216) 102.7G13.3 (360)
17) 113.8G9.2 (450) 109.4G4.7 (749)
86) 111.3G8.9 (234) 106.4G11.7 (390)
31) 116.4G8.9 (216) 112.7G12.9 (359)
7) 36.8G4.0 (450) 30.4G5.9 (749)
6) 35.8G3.8 (234) 30.3G5.1 (390)
1) 37.8G4.08 (216) 30.4G5.9 (359)
17) 366.9G64.2 (450) 366.0G62.2 (750)
86) 335.7G54.8 (234) 332.1G48.4 (390)
31) 400.7G56.0 (216) 398.7G56.5 (359)
(745) 4.85G4.38 (447) 3.50G3.74 (750)
(385) 2.53G2.90 (231) 1.70G2.25 (385)
(360) 7.32G4.34 (216) 5.42G4.05 (360)
nteraction PNT!gender Interaction PNT!day/night phase
0.003 0.467
0.008 0.847
0.489 0.894
0.001 0.017
0.002 0.236
0.001 0.001
ctions of these variables. SBP, systolic blood pressure; DBP, diastolic blood
www.endocrinology-journals.org
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Figure 1 Basal mean arterial blood pressure (MAP) in male and
female offspring exposed to VEH (grey) or DEX (black) during the
last week of gestation. Data are expressed as 6-h rolling averages
over 3 days for each treatment group. nZ4–5 per group.
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Figure 2 Basal heart rate patterns in male and female offspring
exposed to VEH (grey) or DEX (black) during the last week of
gestation. Data are expressed as 6-h rolling averages over 3 days.
nZ4–5 per group.
Prenatal programming of hypertension . D O’REGAN and others 347Haemodynamic and activity responses to graded stress
In utero exposure to DEX has been shown to cause a lifelong
elevation in basal BP when measured by tail-cuff plethysmo-
graphy and carotid cannulation. An exaggerated stress
response to these measurement techniques could account
for apparent hypertension. As shown in Fig. 3 (A, B and E),
male, prenatal DEX-treated offspring were exquisitely
sensitive to stress, displaying graded hypertensive responses
when disturbed by a researcher entering their room and when
restrained. Even weighing elicited a hypersensitive response in
DEX-treated offspring (change in SBP; VEH 10G2 mmHg
and DEX 19G3 mmHg; P!0.05). Moreover, DEX-treated
offspring start with a reduced MAP compared with vehicle
controls (Fig. 3A and B) and maintain their stress-induced
hypertension for longer once released from restraint (Fig. 3E),
and after weighing (change in SBP 5-min post-weighing;
VEH 7G5 mmHg and DEX 23G5 mmHg; P!0.05).
DEX-treated offspring further displayed significantly greater
increases in HR in response to weighing (VEH 117G17 bpm
and DEX 156G25 bpm; P!0.05), and restraint (VEH
86G11 bpm and DEX 136G19 bpm; P!0.05). The greater
tachycardia on disturbance of prenatal DEX offspring was notwww.endocrinology-journals.orgassociated with changes in activity (weighing: VEH 5.2G1
AU, DEX 5G1 AU and restraint: VEH 4.8G1.2 AU, DEX
4.6G1.8 AU). Although there was a significant response in
BP to stress in all females, there was no significant difference
between the VEH- and DEX-treated offspring in response to
disturbance or restraint stress but the recovery period after
stress shows DEX females take longer to return basal levels of
MAP following restraint (Fig. 3C–E).Prenatal DEX causes exaggerated hypertensive responses to
catecholaminergic stimulation
To assess the role of the SNS in mediating this stress-induced
hypertension,we administered a low dose of D-amphetamine, to
induce catecholamine release. While the DEX-treated offspring
showed lower basal MAPs prior to amphetamine administration
(Fig. 4A and B), they showed significantly greater increases in
MAP and HR when treated with the drug compared with
controls (amphetamine treatment F(1,20)Z21.54, PZ0.0002;
prenatal treatment F(1,20)Z13.19, PZ0.0017; Fig. 4A–C).
When the data were separated into male and female responses, it
was demonstrated that there was no indication of a sex-specific
effect (F(1,20)Z0.52, PZ0.48; Fig. 4C).Responsiveness of mesenteric vasculature to NA, AVP and KCL
To examine further the basis for increased responsivity to
catecholaminergic stimulation in DEX-exposed offspring,
resistance (mesenteric) vessels were perfused ex vivo
(Fig. 5A–C). Basal perfusion pressures were similar in the two
groups of rats. Infusion of all agonists caused a concentration-Journal of Endocrinology (2008) 196, 343–352
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D O’REGAN and others . Prenatal programming of hypertension348dependent increase in perfusion pressures, with plateaux reached
in both groups at 5 mM for NA and 10 nM for AVP. However,
tissues from DEX-treated male offspring were significantly more
responsive (the curves from DEX-treated offspring were
significantly different from VEH controls; Fig. 5) and the Vmax
(indicative of numberof receptors) was higher in the DEX group
in response to NA in both sexes (male VEH: 305G13 mmHg;
male DEX: 360G4 mmHg; PZ0.004; t-test. Female VEH:
292G5 mmHg; female DEX: 345G7 mmHg; PZ0.001).Female offspring
Several reports suggest that prenatal ‘programming’ pheno-
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The striking novel finding of this study is that prenatal DEX
results in lower basal BP in the male and female adult
offspring; with the commonly expected hypertensive pheno-
type only being noted when these offspring are subjected to
a stressor, after which they exhibit a prolonged and excessive
hypertensive response. These exaggerated hypertensive
responses are mediated by alterations in the responsivity
of the SNS, being further exaggerated by promotion
of catecholamine release. Additionally, DEX-treated
offspring display greater sensitivity to catecholamines, and
only in males other vasoconstrictors, in resistance (mesen-
teric) vasculature.
Unexpectedly, over many days of recording undisturbed rats
in their home cages, prenatal DEX-exposed adult rats showed
lower BP than controls. This contrasts with both tail cuff
plethysmography and direct carotid cannulation data in this
model (Levitt et al. 1996) and in other models of ‘fetal
programming’ (Woodall et al. 1996, Langley-Evans 1997,
Woods 2006) most of which have generally employed
techniques which involve stressful preheating of the tail and/
or physical restraint or short-term recovery from anaesthesia.
Indeed, several studies have documented by telemetry the stress-
induced hypertension observed following restraint or using thewww.endocrinology-journals.orgtail-cuff protocol (Gross & Luft 2003, Whitesall et al. 2004,
D’Angelo et al. 2005, Kurtz et al. 2005), confirming the
telemetry technique as the ‘gold standard’ for BP recording. In
our study, radiotelemetric measurements were recorded 1 week
after implantation of intra-arterial cannulae to allow complete
recovery from established effects of surgery. Previous studies
have used telemetry to determine BP in other models of fetal
programming following maternal undernutrition (Tonkiss et al.
1998, Khan et al. 2003, Fernandez-Twinn et al. 2006) or uterine
artery ligation (Jansson & Lambert 1999). BP differences by
telemetry have generally been slight, with normotension or at
most mild hypertension, compared with more overt hyperten-
sion using indirect techniques. The quite clear-cut lower basal
BP seen here in males and females in both active and quiescent
phases may therefore reflect specific effects of prenatal
glucocorticoid excess compared with other manipulations,
even though it is acknowledged that glucocorticoid program-
ming is combined with an effect on food intake and maternal
weight (present data; Levitt et al. 1996, Welberg et al. 2001,
Woods 2006). However, short-term measurements of BP, even
over a few hours, failed to attribute statistical significance
between the prenatally treated groups in this study, emphasizing
the statistical power of the telemetric BP measurements,
but highlighting potential differences between studies and
analysis of the data.Journal of Endocrinology (2008) 196, 343–352
D O’REGAN and others . Prenatal programming of hypertension350The hypotension observed in the DEX rats may in part be
attributable to decreased activity in DEX rats compared with
VEH. However, activity differences are greater in the female
DEX rats (compared with female VEH rats), while BP
parameters of hypotension are greater in the male DEX rats
indicating that several parameters may be altered to mediate the
BP changes and that these mechanisms may be sex specific.
Merelyentering the room in which the rats were housed was
sufficient to drive hypertension selectively in male, prenatal
DEX-exposed offspring. When further subjected to a
moderate stressor (weighing) and the more severe restraint
stress the hypertensive responses of the male DEX-treated
offspring were significantly augmented, suggesting increased
sensitivity to environmental stress. An increased reactivity to
stressful environmental stimuli may lead to established
hypertension through frequent transient BP elevations
(Folkow et al. 1978). Whether or not the prenatal DEX-
exposed offspring will eventually become permanently
hypertensive warrants further study, as true life consists of a
constant series of ‘stressful situations’ that have to be dealt with,
and this is not mimicked in undisturbed laboratory animals.
Indeed, the DEX-treated offspring maintained their hyperten-
sion long after the removal of each stressor. Interestingly,
offspring of malnourished dams display a greater hypertensive
response to stress (ammonia odour) echoing the clear stress-
responsive hypertension shown here in prenatal glucocorticoid
programming (Tonkiss et al. 1998). It is therefore tempting to
speculate that prenatal glucocorticoid programming of
exaggerated cardiovascular responses to stress may be the
fundamental change in these models, with permanent
hypertension a secondary phenomenon dependent upon the
postnatal environment and its challenges. This would parallel
the emerging concepts of amplification of the low birth weight
baby metabolic phenotype by postnatal caloric excess (Ozanne
& Nicholas Hales 2005). Moreover, lower basal BP but
enhanced responses to stress align perhaps better with concepts
of adaptive advantages to the predicted (stressful) postnatal
environment of a stressed pregnancy than merely constant
hypertension, which has few apparent benefits.
DEX-treated offspring had higher HR with stress, a marker,
although indirect, of increased sympathetic drive. The
cardiodynamic responses to catecholamine release with
amphetamine (or catecholamine depletion with reserpine,
O’Regan unpublished results) strongly support this notion of a
more responsive SNS in DEX-programmed adult rats.
Amphetamine caused an exaggerated increase in BP in
DEX-treated offspring compared with controls and reserpine
abolished BP differences between DEX and VEH groups
basally and in response to stress. The SNS participates in several
stress responses, even in fetal life (McMillen et al. 2001) and
therefore prenatal exposure to various stressors might affect the
development of sympathetic innervation or its regulation.
Epidemiological evidence of HR variability in infants
demonstrates a positive correlation of this index of sympathetic
activity with low birth weight, suggesting that decreased fetal
growth is associated with a dysfunctional autonomic nervousJournal of Endocrinology (2008) 196, 343–352system which may play a role in programming of BP (Massin
et al. 2001). Indeed in rats, the offspring of prenatal
DEX-treated dams have increased NA turnover in central
brain regions concerned with BP control (Slotkin et al. 1992),
however, cardiac b-adrenergic responses are blunted in low
protein diet-induced-programmed rats (Fernandez-Twinn
et al. 2006). In distinct prenatal rat models, gestational nicotine
impairs the maturation of both central and peripheral
catecholaminergic pathways (Navarro et al. 1990) and hypoxia
alters development of sympathetic centres involved in BP
regulation (Peyronnet et al. 2002), effects which persist into
adulthood. Similarly, ligation of the umbilical artery alters SNS
activity in newborn sheep (Oyama et al. 1992) and adult female
rat offspring (Jansson & Lambert 1999). Taken together, these
data indicate that diverse challenges in utero alter the
development and function of the adult SNS. A recent study
of low birth weight adult humans proposed that their lower
resting muscle sympathetic nerve activities were a function of
altered SNS development (Weitz et al. 2003).
Sex effects on BP regulation in prenatal-programming models
have been shown in a few studies (Kind et al. 2002, O’Regan et al.
2004), but not others (Langley-Evans et al. 1996, Woods & Weeks
2005), although the hypertension may be generated by
sex-specific mechanisms (McMullen & Langley-Evans 2005a,b).
Indeed in humans, females have been shown to have more
efficient regulationof SNSpathways,making them less susceptible
to hypertension (Hinojosa-Laborde et al. 1999). However, in this
study, we show similar effects on BP in males and females, but the
magnitude of hypotension and a greater stress-induced hyperten-
sion is observed in males. The response to catecholamine release
was similar in both sexes. Therefore, further studies will be
required to tease out the mechanisms underpinning the
sex-specific responsivity in this programming model.
Whatever the changes in SNS drive, DEX-treated off-
spring showed greater in vitro mesenteric pressor responses to
NA in both male and females suggesting increased tissue
sensitivity. There were also greater pressor responses to AVP
and a depolarizing potassium solution in males only. Similar
results were obtained in a study looking at female offspring
from mothers treated with DEX throughout pregnancy
(Hadoke et al. 2006). The in vitro perfusion preparation used
in these studies was separated from other in vivo systems (e.g.
circulating angiotensin II, endothelin), suggesting that a
change in receptor binding or alterations in the production of
local vasorelaxants/constrictors underlies the increased
vascular sensitivity. Glucocorticoids may regulate the
synthesis of vasoactive compounds, such as prostaglandins or
nitric oxide, which in turn modulate peripheral vascular
reactivity. Indeed, inhibition of nitric oxide synthesis
(Wallerath et al. 1999) and decreased levels of both
prostaglandin and its mediator adenylate cyclase (Handa
et al. 1984) have been demonstrated in rats with adult DEX-
induced hypertension. Similarly, increased mesenteric vascu-
lature sensitivity to NA has been observed in rats treated as
adults with low doses of DEX (Russo et al. 1990). Whether
the effects are due to the known modest elevations ofwww.endocrinology-journals.org
Prenatal programming of hypertension . D O’REGAN and others 351corticosterone in DEX-programmed rats (Levitt et al. 1996,
Welberg et al. 2001) or reflect primary developmental effects
on the mesenteric vasculature that persist into adult life
remains uncertain. The gender differences in mesenteric
vasculature responses of DEX-treated offspring to both AVP
and KCl are intriguing, and could possibly reflect changes in
vascular reactivity during the reproductive cycle (Dalle Lucca
et al. 2000), and the effect of sex steroids on vascular smooth
muscle sensitivity (Garcia-Villalon et al. 1996). Interestingly,
gender has previously been demonstrated to have no effect on
the sensitivity to NA in both the rat tail artery and aorta (Li &
Duckles 1994, Fulton & Stallone 2002).
The present study provides novel and exciting information
regarding the nature and mechanisms of glucocorticoid-
induced alterations in postnatal BP. As the prenatal glucocorti-
coid exposure models extend our understanding of the fetal
origins phenomena, it is clear that there is a need for replication
and extended studies in humans. Only then, will we be better
equipped to understand both the immediate and long-term
consequences of antenatal glucocorticoid treatment.Acknowledgements
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